Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.1 SEK | -7.24% | -10.48% | +88.00% |
May. 27 | Sweden’s IRLAB Therapeutics Names New CEO | MT |
May. 27 | IRLAB Therapeutics AB Announces CEO Changes, Effective from August 1, 2024 | CI |
Sales 2024 * | 65.65M 6.33M | Sales 2025 * | 138M 13.31M | Capitalization | 731M 70.48M |
---|---|---|---|---|---|
Net income 2024 * | -111M -10.7M | Net income 2025 * | -27M -2.6M | EV / Sales 2024 * | 11 x |
Net cash position 2024 * | 11.93M 1.15M | Net Debt 2025 * | 256M 24.71M | EV / Sales 2025 * | 7.15 x |
P/E ratio 2024 * |
-4.58
x | P/E ratio 2025 * |
-3.94
x | Employees | 32 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 57.48% |
Latest transcript on IRLAB Therapeutics AB
1 day | -7.24% | ||
1 week | -10.48% | ||
Current month | -9.62% | ||
1 month | +28.77% | ||
3 months | -2.08% | ||
6 months | +111.08% | ||
Current year | +88.00% |
Managers | Title | Age | Since |
---|---|---|---|
Clas Sonesson
FOU | Founder | 63 | 12-12-31 |
Chief Executive Officer | 71 | 17-05-05 | |
Nicholas Waters
FOU | Founder | 62 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jan Anders Vedin
BRD | Director/Board Member | 82 | 15-12-31 |
Rein Piir
BRD | Director/Board Member | 66 | 15-12-31 |
Chairman | 66 | 19-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 14.1 | -7.24% | 108,404 |
24-06-04 | 15.2 | -0.98% | 43,292 |
24-06-03 | 15.35 | -1.60% | 33,980 |
24-05-31 | 15.6 | -0.95% | 95,361 |
24-05-30 | 15.75 | 0.00% | 19,888 |
Delayed Quote Nasdaq Stockholm, June 05, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+88.00% | 70.17M | |
+42.69% | 749B | |
+34.11% | 605B | |
-6.87% | 351B | |
+18.74% | 328B | |
+6.76% | 292B | |
+18.08% | 248B | |
-3.44% | 214B | |
+11.35% | 216B | |
+2.64% | 167B |
- Stock Market
- Equities
- IRLAB A Stock